Effects of probiotics on the prevalence of ventilator-associated pneumonia

Evaluation of the effects of probiotics on the prevalence of ventilator-associated pneumonia in patients with multiple trauma admitted to the intensive care unit of brain surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N18

Enrollment

150

Registered

2020-10-30

Start date

2020-11-20

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator-associated pneumonia. Ventilator associated pneumonia

Interventions

Intervention 1: Intervention group: At the beginning of the study, the patients received two daily Lactocare capsules (Bio-Fermentation Pharmaceutical Company-Tehran-Iran) with 20cc of distilled water

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Requires mechanical ventilation

Exclusion criteria

Exclusion criteria: Death during intervention History of lung disease

Design outcomes

Primary

Measure	Time frame
Ventilator-associated pneumonia. Timepoint: Every 12 hours for three days. Method of measurement: Physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Khanbabayi Gol

Tabriz University of Medical Sciences

Khanbabayimehdi69@gmail.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026